| Financial Year |
March 31 2023 |
| Monetary Funds |
449,579,556.41 |
| Held-for-trading Financial Assets |
194,956,349.49 |
| Notes Receivable |
478,532.32 |
| Accounts Receivable |
376,022,354.64 |
| Advances to Suppliers |
13,690,144.60 |
| Other Receivables |
17,588,162.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
249,447,167.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
854,650.86 |
| Total Current Assets |
1,359,781,061.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,127,657.92 |
| Investment Properties |
-- |
| Fixed Assetes |
49,932,938.42 |
| Under-construction Projects |
281,167.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,827,585.86 |
| R&D expenses |
87,980,092.23 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,959,271.91 |
| Deferred Income Tax Assets |
36,247,179.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
235,497,627.32 |
| Total Assets |
1,595,278,689.04 |
| Short-Term Loans |
5,005,437.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,563,509.92 |
| Accounts Payable |
225,803,031.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,454,941.32 |
| Taxes Payable |
36,290,092.71 |
| Interest Payable |
-- |
| Dividend Payable |
767,451.53 |
| Other payables |
23,069,278.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,982,007.54 |
| Other Current Liabilities |
2,481,603.59 |
| Sub-Total of Current Liabilities |
506,629,680.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,139,832.46 |
| Total Liabilities |
511,769,513.22 |
| Paid-In Capital(Or Share Stock) |
367,759,038.00 |
| Capital Surplus |
367,554,497.75 |
| Surplus Reserve |
52,818,046.83 |
| LESS:Treasury Stock |
36,251,316.03 |
| Undistributed Profits |
334,151,220.97 |
| Minority Stockholder's Interest |
-2,699,389.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,086,208,565.11 |
| Owner's Equity（Stockholder's Equity） |
1,083,509,175.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,595,278,689.04 |
